FORMULATION OF ORAL, LONG-ACTING, SOLID, DOSAGE FORMS

被引：0
|
作者：
DELPORTE, JP [1 ]
机构：
[1] UNIV LIEGE,INST PHARM,LIEGE,BELGIUM
来源：
FARMACO-EDIZIONE PRATICA | 1974年 / 29卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：407 / 432
页数：26
相关论文
共 50 条
  • [41] Pharmacokinetics assessment of moxidectin long-acting formulation in cattle
    Dupuy, J.
    Sutra, J. F.
    Alvinerie, M.
    VETERINARY PARASITOLOGY, 2007, 147 (3-4) : 252 - 257
  • [42] Long-Acting Risperidone and Oral Antipsychotics in Schizophrenia
    Kwatra, Shawn G.
    Batson, Nicholas E.
    Kramer, Stephen I.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (23): : 2264 - 2265
  • [43] Efficacy and safety of a novel long-acting risperidone formulation
    Kane, J
    Eerdekens, M
    Keith, S
    Lesem, M
    Karcher, K
    Lindenmayer, JP
    EUROPEAN PSYCHIATRY, 2002, 17 : 193S - 193S
  • [44] SIMPLIFYING ORAL TREATMENT WITH LONG-ACTING RISPERIDONE
    Iranzo, C.
    Arques, S.
    Arnau, F.
    Rubio, T.
    Pino, A.
    Calvillo, F.
    Livianos, L.
    EUROPEAN PSYCHIATRY, 2012, 27
  • [45] PENFLURIDOL - LONG-ACTING ORAL ANTIPSYCHOTIC DRUG
    CLAGHORN, JL
    MATHEW, RJ
    MIRABI, M
    JOURNAL OF CLINICAL PSYCHIATRY, 1979, 40 (02) : 107 - 109
  • [46] Comparative pharmacokinetics of a new oral long-acting formulation of doxycycline hyclate: A canine clinical trial
    Arciniegas Ruiz, Sara Melisa
    Gutierrez Olvera, Lilia
    Bernad Bernad, Maria Josefa
    Caballero Chacon, Sara del Carmen
    Vargas Estrada, Dinorah
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 80 : 9 - 15
  • [47] Long-acting sulfonylureas - long-acting hypoglycaemia
    Veitch, PC
    Clifton-Bligh, RJ
    MEDICAL JOURNAL OF AUSTRALIA, 2004, 180 (02) : 84 - 85
  • [48] Formulation, Design, Optimization, and Characterization of Novel Long-acting Injectable Dosage Form of Anti-psychotic Drug
    Patel, Niraj
    Patel, Rakesh
    Dharamsi, Abhay
    CURRENT DRUG THERAPY, 2024, 19 (06) : 727 - 741
  • [49] GUIDELINES FOR THE DOSAGE OF NEUROLEPTICS .2. CHANGING FROM DAILY ORAL TO LONG-ACTING INJECTABLE NEUROLEPTICS
    SCHULZ, P
    REY, MJ
    DICK, P
    TISSOT, R
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1989, 4 (02) : 105 - 114
  • [50] Formulation of dosage forms
    Shangraw, RF
    IDEA TO PRODUCT: THE PROCESS, 1996, : 51 - 51
12345